
Perspective Therapeutics, Inc.
CATXNYSECIK 728387HealthcareFiscal year ends Dec 31
Reports and events: 405 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-05-1216:34 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069314 |
| 2025-05-1216:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-069301 |
| 2025-05-0117:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-061994 |
| 2025-04-2907:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-059557 |
| 2025-04-1616:30 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000950170-25-054776 |
| 2025-04-1107:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-053023 |
| 2025-03-2816:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-046758 |
| 2025-03-2616:14 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-045242 |
| 2025-03-2616:11 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-045227 |
| 2025-03-1707:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-039826 |
| 2025-03-0408:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-031324 |
| 2025-02-0316:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-012317 |
| 2025-01-2407:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-008603 |
| 2025-01-1308:36 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-004595 |
| 2025-01-0608:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-001712 |
| 2024-12-0421:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-133062 |
| 2024-11-2107:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-129487 |
| 2024-11-1507:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-127384 |
| 2024-11-1216:11 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125399 |
| 2024-11-1216:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125353 |
| 2024-10-1108:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-236468 |
| 2024-09-2016:10 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000950170-24-108407 |
| 2024-09-0507:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-103731 |
| 2024-08-3016:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-102338 |
| 2024-08-1917:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-098685 |
| 2024-08-1317:11 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-096433 |
| 2024-08-1316:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096148 |
| 2024-08-1321:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-095707 |
| 2024-08-1217:22 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095547 |
| 2024-08-1216:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095411 |
| 2024-06-1416:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-073631 |
| 2024-05-3116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-067300 |
| 2024-05-2916:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-065920 |
| 2024-05-2017:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-062549 |
| 2024-05-1516:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-060427 |
| 2024-05-1507:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-060028 |
| 2024-04-1816:09 ET | DEF 14A | Proxy statementPeriod 2024-04-18 | 0000950170-24-045554 |
| 2024-04-1616:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000950170-24-044769 |
| 2024-04-0816:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-24-042575 |
| 2024-04-0316:36 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-24-010889 |
| 2024-03-2808:34 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-009696 |
| 2024-03-2807:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-009691 |
| 2024-03-2517:16 ET | 8-K | 8.01 Other events | 0001437749-24-009256 |
| 2024-03-1916:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-008542 |
| 2024-03-0811:22 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-063234 |
| 2024-03-0818:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-007023 |
| 2024-03-0616:57 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-006845 |
| 2024-02-0516:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-003125 |
| 2024-02-0107:38 ET | SC 13D | Ownership report, active investor | 0001193125-24-021409 |
| 2024-01-2216:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-001852 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:30 ET. Listed shows no prices and gives no investment advice.